We are investigating the safety and tolerability of NTRX-07 in people with mild cognitive impairment or mild to moderate Alzheimer's disease. This study aims to understand how well the treatment works and its effects on patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Mild Cognitive Impairment (MCI) is a condition characterized by noticeable memory or cognitive problems that are greater than expected for a person's age but not severe enough to interfere significantly with daily life.
Mild to Moderate Alzheimer's Disease (AD) is a progressive brain disorder that affects memory, thinking, and behavior, leading to increasing difficulty with daily tasks and communication.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
